The Kidney Transplant Evaluation Process in the Elderly: Reasons for Being Turned down and Opportunities to Improve Cost-Effectiveness in a Single Center
Table 3
Clinical characteristics at time of referral of patients by approval status.
Patients not turned down ()
Patients turned down ()
All patients ()
value
Age at referral, y
64.0 62.0, 67.0
66.0 63.0, 70.0
64.0 62.0, 68.0
<0.001
Female (%)
100 (42)
37 (34)
137 (40)
0.14
Race (%)
0.47
(i) African American
55 (23)
27 (26)
82 (24)
(ii) Caucasian
171 (73)
75 (73)
246 (73)
(iii) Hispanic
5 (2)
1 (1)
6 (2)
(iv) Others
4 (2)
0 (0)
4 (1)
Cause of renal failure
0.052
(i) DM (%)
88 (37)
57 (52)
145 (42)
(ii) HTN (%)
46 (19)
19 (17)
65 (19)
(iii) PKD (%)
19 (8)
3 (3)
22 (6)
(iv) GN (%)
29 (12)
8 (7)
37 (11)
(v) Other (%)
54 (23)
22 (20)
76 (22)
Duration of dialysis, y
0 0, 1
0 0, 2
0 0, 1
0.05
BMI, kg/m2
28.0 24.8, 33.2
28.3 24.3, 32.6
28.0 24.8, 33.0
0.90
DM (%)
111 (47)
64 (59)
175 (51)
0.044
CAD (%)
66 (28)
53 (49)
119 (34)
<0.001
PVD (%)
23 (10)
31 (28)
54 (16)
<0.001
CVA (%)
37 (16)
21 (19)
58 (17)
0.42
COPD (%)
5 (2)
15 (14)
20 (6)
<0.001
Pulmonary HTN (%)
0 (0)
2 (2)
3 (1)
0.19
Cancer (%)
17 (7)
18 (17)
35 (10)
0.008
Liver disease (%)
7 (3)
5 (5)
12 (3)
0.45
Data presented as median interquartile range or frequencies with proportions (%). values from Wilcoxon rank-sum tests for continuous variables and Pearson’s chi-square tests for categorical variables. DM, diabetes mellitus; HTN, hypertension; PKD, polycystic kidney disease; GN, glomerulonephritis; BMI, body mass index; CAD, coronary artery disease; PVD, peripheral vascular disease; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease.
